Ads
related to: astrazeneca pharmaceuticals productshenrymeds.com has been visited by 10K+ users in the past month
Search results
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?
Motley Fool via Yahoo Finance· 12 hours agoAnd with more than $8 billion in cash, equivalents...development deals in China or elsewhere. But is...
AstraZeneca and Nona Biosciences sign agreement for monoclonal antibody
Pharmaceutical Technology via Yahoo Finance· 6 days agoNona Biosciences partnered with Evive Biotech in December 2023 to expedite antibody discovery and...
AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report...
Benzinga· 3 days agoWestern pharmaceutical companies and investors are driving a record number of licensing deals with...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 6 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company announced it was pulling ...
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
Zacks via Yahoo Finance· 5 days agoAstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer...
New data from the Phase 3 NEURO-TTRansform study evaluating WAINUA™ (eplontersen) to be presented at...
WKRN Nashville· 7 days agoIonis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will present new subgroup analyses from Ionis and AstraZeneca's Phase 3 NEURO-TTRansform ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 3 days agoAcne Vulgaris Market to Register Sustainable Growth by 2034, Examines DelveInsight | Key Companies - Dermata Therapeutics, AstraZeneca, Novartis Pharmaceuticals< ...
Hedge Funds are Racking Up Shares of This Healthcare Stock
Insider Monkey via Yahoo Finance· 2 days agoWe recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article...
3 Healthcare Mutual Funds to Buy Amid Rate Cut Uncertainty
Zacks via Yahoo Finance· 6 days agoFPHAX advisors use fundamental analysis of factors like each...Co (24.2%), Novo Nordisk A/S (14.4%)...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
CNBC· 6 days agoBig pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall...
